Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid

Lindor, 2015, ACG clinical guideline: primary sclerosing cholangitis, Am J Gastroenterol, 110, 646, 10.1038/ajg.2015.112 Lindor, 2009, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Hepatology, 50, 808, 10.1002/hep.23082 Poy, 2009, miR-375 maintains normal pancreatic α- and β-cell mass, Proc Natl Acad Sci USA, 106, 5813, 10.1073/pnas.0810550106 Rayner, 2010, MiR-33 contributes to the regulation of cholesterol homeostasis, Science, 328, 1570, 10.1126/science.1189862 Castoldi, 2011, The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice, J Clin Invest, 121, 1386, 10.1172/JCI44883 Padgett, 2009, Primary biliary cirrhosis is associated with altered hepatic microRNA expression, J Autoimmun, 32, 246, 10.1016/j.jaut.2009.02.022 Cheung, 2008, Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression, Hepatology, 48, 1810, 10.1002/hep.22569 Jopling, 2005, Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA, Science, 309, 1577, 10.1126/science.1113329 Zhang, 2011, Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1, Hepatology, 53, 1476, 10.1002/hep.24195 Tsai, 2012, MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J Clin Invest, 122, 2884, 10.1172/JCI63455 Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci USA, 108, 5003, 10.1073/pnas.1019055108 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105 Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032 Povero, 2022, Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis, Sci Rep, 12, 3027, 10.1038/s41598-022-06809-0 Li, 2012, Method for microRNA isolation from clinical serum samples, Anal Biochem, 431, 69, 10.1016/j.ab.2012.09.007 Hastie T, Tibshirani R, Narasimhan B, Chu G. Impute: Imputation for microarray data. R package version 1.56.0. https://git.bioconductor.org/packages/impute Accessed 26 March 2023. Ritchie, 2015, LIMMA powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, 43, e47, 10.1093/nar/gkv007 Backes, 2016, miEAA: microRNA enrichment analysis and annotation, Nucleic Acids Res, 44, W110, 10.1093/nar/gkw345 Afsari, 2015, switchBox: an R package for k-Top Scoring Pairs classifier development, Bioinformatics, 31, 273, 10.1093/bioinformatics/btu622 Hu, 2015, The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis, Clin Sci (Lond), 129, 305, 10.1042/CS20140012 Zhuang, 2016, MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST, Cell Death Dis, 7, 10.1038/cddis.2016.100 Gui, 2011, Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies, Clin Sci (Lond), 120, 183, 10.1042/CS20100297 Chou, 2018, miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions, Nucleic Acids Res, 46, D296, 10.1093/nar/gkx1067 Voigtländer, 2015, MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and/or cholangiocarcinoma, PLoS One, 10, 10.1371/journal.pone.0139305 Wu, 2013, The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas, Brain Res, 1529, 16, 10.1016/j.brainres.2013.07.031 Sengupta, 2009, MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells, Stem Cells, 27, 1524, 10.1002/stem.84 Bernuzzi, 2016, Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma, Clin Exp Immunol, 185, 61, 10.1111/cei.12776 Afanasyeva, 2011, MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival, Cell Death Differ, 18, 974, 10.1038/cdd.2010.164 Dinh, 2019, MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma, Cell Mol Gastroenterol Hepatol, 7, 803, 10.1016/j.jcmgh.2019.01.008 Lin, 2016, Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma, Oncogene, 35, 3376, 10.1038/onc.2015.396 Sun, 2014, Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b–2 miRNA cluster in prostate cancer cells, Oncogene, 33, 1448, 10.1038/onc.2013.77 Eaton, 2011, High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis, Am J Gastroenterol, 106, 1638, 10.1038/ajg.2011.156 Liang, 2010, MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2, Hepatology, 52, 1731, 10.1002/hep.23904 Wang, 2009, Circulating microRNAs, potential biomarkers for drug-induced liver injury, Proc Natl Acad Sci USA, 106, 4402, 10.1073/pnas.0813371106 Li, 2012, MicroRNAs in common human diseases, Genomics Proteomics Bioinformatics, 10, 246, 10.1016/j.gpb.2012.07.005 Lee, 2017, The importance of standardization on analyzing circulating RNA, Mol Diagn Ther, 21, 259, 10.1007/s40291-016-0251-y Bowlus, 2023, AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma, Hepatology, 77, 659, 10.1002/hep.32771